Copyright © Inderes 2011 - present. All rights reserved.

I-tech

54,40 SEK

+7,94 %

Mindre end 1K følgere

ITECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

+7,94 %
+4,21 %
+3,03 %
-26,88 %
-52,49 %
-4,56 %
+0,37 %
-34,46 %
+120,56 %

I-tech operates in marine technology. The company conducts research and development of substances that inhibit marine fouling on ship hulls. In addition, the products can be used for various marine installations in fish farming and offshore. Customers are found in the marine paint industry and among other players in the shipping industry. I-Tech was founded in 2000 and has its headquarters in Mölndal.

Læs mere
Markedsværdi
652,68 mio. SEK
Aktieomsætning
8,35 mio. SEK
Omsætning
179,45 mio.
EBIT %
25,35 %
P/E
16,48
Udbytteafkast, %
1,84 %
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
5.2
2026

Årsrapport '25

7.5
2026

Delårsrapport Q1'26

21.8
2026

Delårsrapport Q2'26

ViserAlle indholdstyper
Eksterne analyser

I-tech: Proposed non-renewal of Selektope in the EU - ABG

* European Commission drafts proposal for non-renewal of Selektope* Limited impact on near-term estimates, EU ~2% of total sales* Voting expected to occur some time in H1'26, final decision in mid-26European Commission drafts proposal for non-renewal...

I-tech

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Eksterne analyser

I-tech: Customer slowdown tempers growth - ABG

* Q3 softer due to sizeable customer trimming '25 volumes* '25e-'27e sales cut by 11-6% and '26e-'27e EBIT by 12-8%* We believe I-Tech remains strongly positioned to grow market shareGrowth dampened by customer volume cutsI-Tech reported weaker than ...

I-tech
Eksterne analyser

I-tech: Q3 impacted by weaker market conditions - ABG

Sales -18% vs. ABGSCe, EBIT SEK 11m vs. ABGSCe 16m* Newbuild market down 50% y-o-y, affecting growth* Sizeable customer has reduced planned volumes for '25Q3 resultsQ3 sales came in lower than expected at SEK 41m (-18% vs. ABGSCe 50m). The company writes...

I-tech
Eksterne analyser

I-tech: Sales recovery expected in Q3 - ABG

* Report out on 17 October* Q3e sales of SEK 50m, +23% y-o-y, EBIT SEK 16m (9m)* Q3 rebound expected after Q2 dip Q3 expectations We estimate Q3 sales of SEK 50m, +23% y-o-y (+35% organic, -12% FX). We expect Q3 to demonstrate that Q2 was a temporary...

I-tech
Eksterne analyser

I-tech: A pause, not a stop - ABG

* Weaker Q2 due to natural quarterly variations* Cut '25e-'27e EBIT by 12-13%* Demand intact, rebound expected in Q3Growth halted, but we expect a rebound in Q3I-Tech reported weaker Q2 sales of SEK 32m (-39% vs. ABGSCe, -26% y-o-y) and EBIT of SEK 5m...

I-tech
Eksterne analyser

I-tech: Big Q2 miss halts sales growth - ABG

* Sales -39% vs. ABGSCe, EBIT SEK 5m vs. ABGSCe 16m * Weak Q2 due to inventory build-up following strong Q4/Q1* Gross margin continues to improve (59% vs. ABGSCe 56%) Weaker Q2 than expected Sales came in lower than expected at SEK 32m (-39% vs. ABGSCe...

I-tech
Eksterne analyser

I-Tech: Resilient growth ahead despite FX headwinds - ABG

Q2e sales of SEK 52m, 22% y-o-y, adj. EBIT of SEK 17m (12m) FX headwinds, but we expect customer growth to remain solid Minor estimate changes ahead of report Q2 expectations We anticipate a negative FX impact in Q2 from the depreciation of the USD/SEK...

I-tech
Eksterne analyser

I-tech: Announce one year extension of Selektope approval - ABG

Q1 revenues 3% below, EBIT DKK -1m vs. ABGSCe DKK 11m FY'25 guidance maintained, as expected Consensus to lower '25e EBITDA by ~10% on Q1 miss Q1 revenues 3% below, EBIT DKK -1m vs. ABGSCe DKK 11m North Media's Q1 revenues of DKK 311m came in 3% below...

I-tech
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.